| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.28B | 31.38B | 29.10B | 27.07B | 25.01B | 24.60B |
| Gross Profit | 5.56B | 5.95B | 5.20B | 4.69B | 4.49B | 4.45B |
| EBITDA | 2.76B | 3.06B | 2.42B | 2.01B | 1.83B | 1.75B |
| Net Income | 1.67B | 2.04B | 1.54B | 1.20B | 1.08B | 1.06B |
Balance Sheet | ||||||
| Total Assets | 27.93B | 34.72B | 30.33B | 28.75B | 28.05B | 25.79B |
| Cash, Cash Equivalents and Short-Term Investments | 6.90B | 3.26B | 3.17B | 2.26B | 2.33B | 1.85B |
| Total Debt | 940.00M | 978.00M | 2.84B | 3.43B | 5.47B | 3.93B |
| Total Liabilities | 11.18B | 16.62B | 14.45B | 15.54B | 16.49B | 14.85B |
| Stockholders Equity | 16.75B | 18.09B | 15.88B | 13.21B | 11.56B | 10.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.17B | -26.00M | 2.26B | -555.00M | -34.00M |
| Operating Cash Flow | 0.00 | 3.81B | 339.00M | 3.19B | -79.00M | 1.64B |
| Investing Cash Flow | 0.00 | -1.30B | 160.00M | -771.00M | -498.00M | -1.78B |
| Financing Cash Flow | 0.00 | -2.42B | 391.00M | -2.50B | 1.04B | 154.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥438.71B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥697.86B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
72 Outperform | ¥33.39B | 15.64 | ― | 1.91% | 3.14% | 11.04% | |
70 Outperform | ¥80.96B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | ¥167.94B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥919.59B | 36.79 | 2.99% | 2.62% | 3.51% | ― |